Churg-Strauss syndrome secondary to antileucotriene therapy in a patient not receiving oral corticosteroids

Clinical and Experimental Dermatology

Volumn 34, Issue 7, 2009, Pages

  Jennings, L ^a   Ho, W L ^a   Gulmann, C ^a   Murphy, G M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE; MONTELUKAST; SALBUTAMOL;

ADULT; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; PRIORITY JOURNAL;

ACETATES; ASTHMA; CHURG-STRAUSS SYNDROME; DRUG ERUPTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; YOUNG ADULT;

EID: 70349499515     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03431.x     Document Type: Letter

References (5)

1. Wechsler ME, Garpestad E, Flier SR et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998 279 : 455 457.
2. Knoell DL, Lucas J, Allen JN. Churg-Strauss syndrome associated with zafirlukast. Chest 1998 114 : 332 334.
3. English J III., Greer KE, McCrone SA et al. Fluticasone-associated cutaneous allergic granulomatous vasculitis. J Drugs Dermatol 2003 2 : 326 329.
4. Nathani N, Little MA, Kunst H et al. Churg Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax 2008 63 : 883 888.
5. Hauser T, Mahr A, Metzler C et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 2008 63 : 677 682.